ArticleBMC chemistry2026
Synthesis, X-ray, molecular electronic property investigation, and molecular docking analysis of two imino Schiff bases.
Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we report the first synthesis and comprehensive characterization of two positional isomers of iodo-substituted imino Schiff bases, Im1 was synthesized using 2-iodoaniline, whereas Im2 was obtained from 4-iodoaniline. Compound Im1 represents a new derivative, while Im2 is fully characterized crystallographically for the first time. The structures were confirmed by FT-IR, UV-Vis, ¹H and ¹³C NMR spectroscopy, and single-crystal X-ray diffraction, which revealed that Im2 crystallizes in the monoclinic space group P2₁/c. Hirshfeld surface and fingerprint analyses provided insights into key intermolecular interactions governing crystal stability. Among the two compounds, Im2 exhibited the highest antibacterial activity, forming an 11.00 ± 0.00 mm inhibition zone against Klebsiella pneumonia, whereas Im1 demonstrated the strongest inhibition (11.67 ± 0.47 mm) against Escherichia coli. DFT calculations (B3LYP/LANL2DZ) and molecular docking with the FimH receptor (PDB ID: 8BVD) revealed electronic and structural features influencing binding affinity (-3.737 to -4.266 kcal/mol). ADME-T predictions indicated favorable drug-likeness, suggesting these Schiff bases as promising scaffolds for further optimization toward antibacterial development. This novel comparative analysis of the two imines revealed the pronounced influence of ortho and para-iodine substitution on biological activity and inhibitory potency, demonstrating a clear structure-activity relationship (SAR) governing their antibacterial performance. In the future, Im1 and Im2, when combined with other bioactive scaffolds, may serve as promising candidates for enhanced therapeutic and biological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.